Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Real Estate Companies: Sabra Healthcare REIT (SBRA), Iron Mountain (IRM) and Rayonier (RYN)

Tipranks - Tipranks - Fri Nov 7, 2025

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Sabra Healthcare REIT (SBRA – Research Report), Iron Mountain (IRM – Research Report) and Rayonier (RYN – Research Report).

Meet Your ETF AI Analyst

Sabra Healthcare REIT (SBRA)

In a report released today, Michael Lewis from Truist Financial maintained a Hold rating on Sabra Healthcare REIT. The company’s shares closed last Wednesday at $18.20.

According to TipRanks.com, Lewis is a 5-star analyst with an average return of 8.7% and a 59.5% success rate. Lewis covers the NA sector, focusing on stocks such as SmartStop Self Storage REIT, Inc., American Healthcare REIT, Inc., and Easterly Government Properties. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sabra Healthcare REIT with a $20.50 average price target, implying a 14.4% upside from current levels. In a report released yesterday, BMO Capital also maintained a Hold rating on the stock with a $22.00 price target.

See the top stocks recommended by analysts >>

Iron Mountain (IRM)

Truist Financial analyst Tobey Sommer maintained a Buy rating on Iron Mountain today. The company’s shares closed last Wednesday at $100.47.

According to TipRanks.com, Sommer is a 4-star analyst with an average return of 6.7% and a 57.6% success rate. Sommer covers the Industrial Goods sector, focusing on stocks such as Amentum Holdings, Inc., Heidrick & Struggles, and GFL Environmental. ;'>

Currently, the analyst consensus on Iron Mountain is a Strong Buy with an average price target of $125.57, representing a 21.2% upside. In a report released today, J.P. Morgan also maintained a Buy rating on the stock with a $111.00 price target.

Rayonier (RYN)

Truist Financial analyst Michael Roxland maintained a Hold rating on Rayonier today. The company’s shares closed last Wednesday at $22.08.

According to TipRanks.com, Roxland is a 1-star analyst with an average return of -0.7% and a 40.1% success rate. Roxland covers the NA sector, focusing on stocks such as International Paper Co, Ardagh Metal Packaging, and Graphic Packaging. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Rayonier with a $27.00 average price target, representing a 23.5% upside. In a report issued on October 23, Citi also maintained a Hold rating on the stock with a $27.00 price target.

Read More on SBRA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).